527 related articles for article (PubMed ID: 30429496)
1. The beneficial effects of Lactobacillus reuteri ADR-1 or ADR-3 consumption on type 2 diabetes mellitus: a randomized, double-blinded, placebo-controlled trial.
Hsieh MC; Tsai WH; Jheng YP; Su SL; Wang SY; Lin CC; Chen YH; Chang WW
Sci Rep; 2018 Nov; 8(1):16791. PubMed ID: 30429496
[TBL] [Abstract][Full Text] [Related]
2. Metabolic effects of Lactobacillus reuteri DSM 17938 in people with type 2 diabetes: A randomized controlled trial.
Mobini R; Tremaroli V; Ståhlman M; Karlsson F; Levin M; Ljungberg M; Sohlin M; Bertéus Forslund H; Perkins R; Bäckhed F; Jansson PA
Diabetes Obes Metab; 2017 Apr; 19(4):579-589. PubMed ID: 28009106
[TBL] [Abstract][Full Text] [Related]
3. Clinical application of probiotics in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study.
Tonucci LB; Olbrich Dos Santos KM; Licursi de Oliveira L; Rocha Ribeiro SM; Duarte Martino HS
Clin Nutr; 2017 Feb; 36(1):85-92. PubMed ID: 26732026
[TBL] [Abstract][Full Text] [Related]
4. Effect of adjuvant probiotic therapy (Lactobacillus reuteri) in the treatment of periodontitis associated with diabetes mellitus: clinical, controlled, and randomized study.
Jardini MAN; Pedroso JF; Ferreira CL; Nunes CMM; Reichert CO; Aldin MN; Figueiredo Neto AM; Levy D; Damasceno NRT
Clin Oral Investig; 2024 Jan; 28(1):80. PubMed ID: 38183505
[TBL] [Abstract][Full Text] [Related]
5. Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: a double blind prospective study.
del Campo R; Garriga M; Pérez-Aragón A; Guallarte P; Lamas A; Máiz L; Bayón C; Roy G; Cantón R; Zamora J; Baquero F; Suárez L
J Cyst Fibros; 2014 Dec; 13(6):716-22. PubMed ID: 24636808
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant Probiotics of
Wang CH; Yen HR; Lu WL; Ho HH; Lin WY; Kuo YW; Huang YY; Tsai SY; Lin HC
Front Endocrinol (Lausanne); 2022; 13():754401. PubMed ID: 35299968
[TBL] [Abstract][Full Text] [Related]
7. Probiotics to prevent infantile colic.
Ong TG; Gordon M; Banks SS; Thomas MR; Akobeng AK
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012473. PubMed ID: 30865287
[TBL] [Abstract][Full Text] [Related]
8. Oral Microbiota Shift after 12-Week Supplementation with Lactobacillus reuteri DSM 17938 and PTA 5289; A Randomized Control Trial.
Romani Vestman N; Chen T; Lif Holgerson P; Öhman C; Johansson I
PLoS One; 2015; 10(5):e0125812. PubMed ID: 25946126
[TBL] [Abstract][Full Text] [Related]
9. Effect of multi-strain probiotics (multi-strain microbial cell preparation) on glycemic control and other diabetes-related outcomes in people with type 2 diabetes: a randomized controlled trial.
Firouzi S; Majid HA; Ismail A; Kamaruddin NA; Barakatun-Nisak MY
Eur J Nutr; 2017 Jun; 56(4):1535-1550. PubMed ID: 26988693
[TBL] [Abstract][Full Text] [Related]
10. [Influence of Lactobacillus reuteri SL001 on intestinal microbiota in AD model mice and C57BL/6 mice].
Liu M; Hu R; Guo Y; Sun W; Li J; Fan M; Wang Y; Du H; Tang Z; Chai C
Sheng Wu Gong Cheng Xue Bao; 2020 Sep; 36(9):1887-1898. PubMed ID: 33164464
[TBL] [Abstract][Full Text] [Related]
11. The Effects of Limosilactobacillus reuteri LR-99 Supplementation on Body Mass Index, Social Communication, Fine Motor Function, and Gut Microbiome Composition in Individuals with Prader-Willi Syndrome: a Randomized Double-Blinded Placebo-Controlled Trial.
Kong XJ; Liu K; Zhuang P; Tian R; Liu S; Clairmont C; Lin X; Sherman H; Zhu J; Wang Y; Fong M; Li A; Wang BK; Wang J; Yu Z; Shen C; Cui X; Cao H; Du T; Wan G; Cao X
Probiotics Antimicrob Proteins; 2021 Dec; 13(6):1508-1520. PubMed ID: 34115318
[TBL] [Abstract][Full Text] [Related]
12. Oral supplementation with probiotic L. reuteri NCIMB 30242 increases mean circulating 25-hydroxyvitamin D: a post hoc analysis of a randomized controlled trial.
Jones ML; Martoni CJ; Prakash S
J Clin Endocrinol Metab; 2013 Jul; 98(7):2944-51. PubMed ID: 23609838
[TBL] [Abstract][Full Text] [Related]
13. Survival of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the human gastrointestinal tract with daily consumption of a low-fat probiotic spread.
Dommels YE; Kemperman RA; Zebregs YE; Draaisma RB; Jol A; Wolvers DA; Vaughan EE; Albers R
Appl Environ Microbiol; 2009 Oct; 75(19):6198-204. PubMed ID: 19684171
[TBL] [Abstract][Full Text] [Related]
14. Lactobacillus reuteri for Infants with Colic: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Fatheree NY; Liu Y; Taylor CM; Hoang TK; Cai C; Rahbar MH; Hessabi M; Ferris M; McMurtry V; Wong C; Vu T; Dancsak T; Wang T; Gleason W; Bandla V; Navarro F; Tran DQ; Rhoads JM
J Pediatr; 2017 Dec; 191():170-178.e2. PubMed ID: 28969890
[TBL] [Abstract][Full Text] [Related]
15. Lactobacillus reuteri strain combination in Helicobacter pylori infection: a randomized, double-blind, placebo-controlled study.
Francavilla R; Polimeno L; Demichina A; Maurogiovanni G; Principi B; Scaccianoce G; Ierardi E; Russo F; Riezzo G; Di Leo A; Cavallo L; Francavilla A; Versalovic J
J Clin Gastroenterol; 2014; 48(5):407-13. PubMed ID: 24296423
[TBL] [Abstract][Full Text] [Related]
16.
Tenorio-Jiménez C; Martínez-Ramírez MJ; Del Castillo-Codes I; Arraiza-Irigoyen C; Tercero-Lozano M; Camacho J; Chueca N; García F; Olza J; Plaza-Díaz J; Fontana L; Olivares M; Gil Á; Gómez-Llorente C
Nutrients; 2019 Jul; 11(8):. PubMed ID: 31370223
[TBL] [Abstract][Full Text] [Related]
17.
Koppinger MP; Lopez-Pier MA; Skaria R; Harris PR; Konhilas JP
Am J Physiol Heart Circ Physiol; 2020 Jul; 319(1):H32-H41. PubMed ID: 32412785
[TBL] [Abstract][Full Text] [Related]
18. Crying Time and RORγ/FOXP3 Expression in Lactobacillus reuteri DSM17938-Treated Infants with Colic: A Randomized Trial.
Savino F; Garro M; Montanari P; Galliano I; Bergallo M
J Pediatr; 2018 Jan; 192():171-177.e1. PubMed ID: 28969887
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the effect of Lactobacillus reuteri V3401 on biomarkers of inflammation, cardiovascular risk and liver steatosis in obese adults with metabolic syndrome: a randomized clinical trial (PROSIR).
Tenorio-Jiménez C; Martínez-Ramírez MJ; Tercero-Lozano M; Arraiza-Irigoyen C; Del Castillo-Codes I; Olza J; Plaza-Díaz J; Fontana L; Migueles JH; Olivares M; Gil Á; Gomez-Llorente C
BMC Complement Altern Med; 2018 Nov; 18(1):306. PubMed ID: 30453950
[TBL] [Abstract][Full Text] [Related]
20.
Hsieh PS; Ho HH; Hsieh SH; Kuo YW; Tseng HY; Kao HF; Wang JY
BMJ Open Diabetes Res Care; 2020 Apr; 8(1):. PubMed ID: 32332068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]